Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer · Localized Prostate Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States
Contact: Study coordinator (Rohan Garje, MD) · rohan.garje@baptisthealth.net · 786-596-2000

Study leads

Rohan Garje, M.D.
Principal Investigator
Miami Cancer Institute at Baptist Health, Inc.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Prostate Cancer · Prostate Cancer (Diagnosis) · High-risk Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

San Francisco, United States

Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

Prostate Cancer Patients Treated by Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Cairo, Egypt · Shibīn al Kawm, Egypt

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Tucson, United States

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Goodyear, United States · Scottsdale, United States